Revolution Medicines, Inc. (RVMD) NASDAQ
151.31
-12.37(-7.56%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 15.14B |
| Enterprise Value | 14.92B |
| P/E Ratio | -21.85 |
| PEG Ratio | 0.45 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 19.98 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -23.81 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.61 |
| Return On Equity | -0.83 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -16.56M |
| EBITDA | -1.09B |
| Net Income | -1.13B |
| Diluted EPS | -5.95 |
Balance Sheet
| Total Cash | 1.91B |
| Total Cash/Share | 9.63 |
| Total Debt | 156.63M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 6.8 |
| Book Value Per Share | 7.57 |
Price History
| 52-Week Change | 272.23 |
| 52-Week High | 166.5 |
| 52-Week Low | 34 |
| Moving Average 50 Days | 132.59 |
| Moving Average 200 Days | 88.19 |
Statistics
| Average Volume | 3.01M |
| Shares Outstanding | 212.6M |
| % Held by Institutions | 104.29 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
